Clinical Trials Directory

Trials / Unknown

UnknownNCT05885217

Measurement of Serum microRNA in Acne Vulgaris Patient

Evaluation of Serum MicroRNA in Acne Vulgaris and Relation to Acne Severity

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
South Valley University · Academic / Other
Sex
All
Age
10 Years – 50 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to: 1. Evaluation of serum microRNA in acne vulgaris and compare to control group 2. Evaluate correlation with acne vulgaris severity

Detailed description

Acne vulgaris is a common chronic skin disease involving blockage and inflammation of pilosebaceous units. Acne vulgaris is characterized by non-inflammatory, open or closed comedones and by Inflammatory lesions include papules, pustules and nodules. Affecting mostly the face but also the back and chest. Acne vulgaris may have a psychological impact on any patient, regardless of the severity or the grade of the disease. Prevalence of self-reported acne was 34.7%. Females significantly reported acne more frequently than males (39.1% vs. 30.3%) Prevalence of clinically confirmed acne was 24.4%, with higher rates among females (28.6%) than males (20.2%).(4) the pathogenesis result from increased sebum production (due to increased activity of androgens and (IGF-1), excessive deposition of keratin in pilosebaceous follicles leading to comedo formation, colonization of the follicle by Propionibacterium acnes bacteria, and the local release of pro-inflammatory chemicals in the skin through certain inflammatory mechanisms. recently, Inflammation is a key feature in the pathogenesis of acne vulgaris , with various chemokines and cytokines that contribute to fuel a vicious cycle. In addition, genetics is also a key factor in the pathophysiology of acne. MicroRNAs(MiRNAs) are a class of endogenous, short (19-23 nucleotides in length), which regulate the expression of genes via translational repression or degradation of target messenger RNAs.Recently, the role of miRNAs has also been reviewed for the pathogenesis of various inflammatory skin conditions such as psoriasis, eczema, atopic dermatitis and toxic epidermal necrolysis. MiRNAs are present not only in the intracellular space, but also in extracellular spaces such as serum, urine, and saliva. This study is the first to evaluate microRNA in serum of acne vulgaris patients.

Conditions

Interventions

TypeNameDescription
OTHERmeasure serum MicroRNA in acne vulgarisQuantitively assay of serum microRNA level will be measured control by performing an enzyme-linked immune sorbent assay (E LISA)

Timeline

Start date
2023-08-01
Primary completion
2024-04-01
Completion
2024-10-01
First posted
2023-06-01
Last updated
2023-07-05

Source: ClinicalTrials.gov record NCT05885217. Inclusion in this directory is not an endorsement.